Truist Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.1M Sell
90,782
-8,048
-8% -$2.98M 0.04% 317
2026
Q1
$28.9M Sell
98,830
-40,057
-29% -$13.2M 0.04% 340
2025
Q4
$48.7M Sell
138,887
-16,372
-11% -$5.53M 0.06% 243
2025
Q3
$50.2M Sell
155,259
-57,451
-27% -$17.9M 0.07% 239
2025
Q2
$82.7M Sell
212,710
-51,058
-19% -$20.5M 0.12% 160
2025
Q1
$115M Buy
263,768
+14,072
+6% +$5.65M 0.18% 119
2024
Q4
$92.1M Sell
249,696
-9,394
-4% -$3.93M 0.14% 136
2024
Q3
$135M Sell
259,090
-290,984
-53% -$155M 0.21% 92
2024
Q2
$298M Buy
550,074
+5,026
+0.9% +$2.66M 0.45% 45
2024
Q1
$283M Buy
545,048
+11,584
+2% +$5.76M 0.43% 49
2023
Q4
$252M Sell
533,464
-48,655
-8% -$22.5M 0.4% 54
2023
Q3
$253M Buy
582,119
+59,628
+11% +$27M 0.42% 51
2023
Q2
$232M Sell
522,491
-70,176
-12% -$32.4M 0.39% 53
2023
Q1
$273M Sell
592,667
-16,594
-3% -$7.9M 0.47% 43
2022
Q4
$313M Sell
609,261
-5,794
-0.9% -$2.94M 0.55% 39
2022
Q3
$279M Buy
615,055
+14,599
+2% +$6.99M 0.54% 37
2022
Q2
$290M Sell
600,456
-19,112
-3% -$9.45M 0.53% 37
2022
Q1
$304M Sell
619,568
-22,716
-4% -$10.4M 0.48% 42
2021
Q4
$298M Sell
642,284
-7,810
-1% -$3.29M 0.45% 52
2021
Q3
$242M Sell
650,094
-10,561
-2% -$4.01M 0.4% 64
2021
Q2
$252M Sell
660,655
-11,242
-2% -$4.3M 0.41% 57
2021
Q1
$241M Buy
671,897
+59,555
+10% +$19.2M 0.42% 59
2020
Q4
$197M Buy
612,342
+6,406
+1% +$1.97M 0.38% 62
2020
Q3
$163M Sell
605,936
-78,707
-11% -$21.2M 0.36% 66
2020
Q2
$180M Buy
684,643
+23,982
+4% +$6.4M 0.4% 58
2020
Q1
$150M Buy
660,661
+116,330
+21% +$31.7M 0.39% 60
2019
Q4
$164M Buy
544,331
+453,630
+500% +$125M 0.33% 71
2019
Q3
$21.8M Sell
90,701
-186
-0.2% -$51K 0.37% 65
2019
Q2
$25.6M Sell
90,887
-1,220
-1% -$333K 0.44% 56
2019
Q1
$26.4M Sell
92,107
-4,312
-4% -$1.25M 0.47% 49
2018
Q4
$25.3M Sell
96,419
-2,921
-3% -$803K 0.52% 44
2018
Q3
$27.2M Sell
99,340
-5,221
-5% -$1.36M 0.49% 50
2018
Q2
$24.9M Sell
104,561
-3,908
-4% -$905K 0.47% 50
2018
Q1
$23.8M Sell
108,469
-10,253
-9% -$2.41M 0.45% 53
2017
Q4
$26.7M Sell
118,722
-4,699
-4% -$1M 0.5% 47
2017
Q3
$23.4M Sell
123,421
-7,469
-6% -$1.42M 0.45% 52
2017
Q2
$24.6M Sell
130,890
-10,610
-7% -$1.91M 0.49% 47
2017
Q1
$23.4M Sell
141,500
-12,022
-8% -$1.91M 0.47% 48
2016
Q4
$22.1M Buy
153,522
+827
+0.5% +$111K 0.45% 49
2016
Q3
$19.1M Buy
152,695
+2,696
+2% +$348K 0.39% 68
2016
Q2
$19.7M Buy
149,999
+46,191
+44% +$6.32M 0.41% 63
2016
Q1
$14.4M Buy
103,808
+4,372
+4% +$584K 0.37% 68
2015
Q4
$13.9M Buy
99,436
+1,809
+2% +$249K 0.36% 72
2015
Q3
$13.7M Sell
97,627
-9,825
-9% -$1.48M 0.36% 77
2015
Q2
$17.6M Sell
107,452
-14,551
-12% -$2.32M 0.48% 51
2015
Q1
$18.8M Sell
122,003
-19,682
-14% -$2.8M 0.54% 43
2014
Q4
$17.8M Sell
141,685
-8,321
-6% -$1.03M 0.52% 53
2014
Q3
$17.9M Sell
150,006
-3,552
-2% -$407K 0.54% 50
2014
Q2
$16.5M Sell
153,558
-6,403
-4% -$660K 0.5% 54
2014
Q1
$15.9M Buy
159,961
+8,906
+6% +$805K 0.5% 50
2013
Q4
$14M Buy
151,055
+8,946
+6% +$795K 0.45% 62
2013
Q3
$11.9M Buy
142,109
+10,705
+8% +$917K 0.42% 62
2013
Q2
$10.8M Buy
+131,404
New +$9.83M 0.4% 62

Other funds holding ELV

Truist Financial's ELV Position: Q2 2026 in Review

Truist Financial reduced its Elevance Health (ELV) stake by 8.1% in Q2 2026, selling an estimated $2.98M and leaving 90,782 shares worth $35.1M. The position accounts for 0.04% of the portfolio, ranked #317.

Truist Financial first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $313M in Q4 2022. 576 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Truist Financial held 90,782 shares of Elevance Health worth $35.1M as of Q2 2026.
  • Truist Financial sold 8,048 Elevance Health shares in Q2 2026, an estimated $2.98M.
  • Elevance Health made up 0.04% of Truist Financial's portfolio in Q2 2026, its #317 holding.
  • Truist Financial first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Truist Financial's Elevance Health position peaked at $313M in Q4 2022.
  • 576 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.